Silvia Geraci

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

Dave Singh, Kai Michael Beeh, Brendan Colgan et al. · Respiratory Research · 2019 · 80 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐blind, randomised, placebo‐controlled trial

Line Borgwardt, Nathalie Guffon, Yasmina Amraoui et al. · Journal of Inherited Metabolic Disease · 2018 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +7

Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis

Allan M. Lund, Line Borgwardt, Federica Cattaneo et al. · Journal of Inherited Metabolic Disease · 2018 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis

Paul Harmatz, Federica Cattaneo, Diego Ardigò et al. · Molecular Genetics and Metabolism · 2018 · 49 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +13

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Nassim Kamar, Élisabeth Cassuto, Giovanni Piotti et al. · Advances in Therapy · 2018 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16